n-acetylmannosamine has been researched along with Muscular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayman, L; Berry, SM; Bradley, K; Carrillo, N; Ciccone, C; Class, B; Coffey, CS; Driscoll, C; Gahl, WA; Heiss, JD; Huizing, M; Jodarski, C; Joe, G; Leoyklang, P; Liu, CY; Malicdan, MC; Parks, R; Perreault, J; Quintana, M; Shrader, JA; Slota, C; Van Wart, S | 1 |
| Alonzi, DS; Blériot, Y; Butters, TD; Dorward, H; Gahl, WA; Huizing, M; Kukushkin, NV; Le Poëc-Celic, E; Leoyklang, P; Patzel, KA; Sollogoub, M; Xu, B; Yardeni, T; Zhang, Y | 1 |
1 trial(s) available for n-acetylmannosamine and Muscular Diseases
| Article | Year |
|---|---|
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study.
Topics: Adult; Distal Myopathies; Hexosamines; Humans; Muscular Diseases; N-Acetylneuraminic Acid | 2021 |
1 other study(ies) available for n-acetylmannosamine and Muscular Diseases
| Article | Year |
|---|---|
Non-specific accumulation of glycosphingolipids in GNE myopathy.
Topics: Animals; Case-Control Studies; Cells, Cultured; Female; Fibroblasts; Glycosphingolipids; Hexosamines; Humans; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Muscles; Muscular Diseases; Mutation; N-Acetylneuraminic Acid | 2014 |